Flagstar Bank NA vs Humana Inc — how do they compare? Flagstar Bank NA trades at $11.32 (market cap $4.71B), while Humana Inc trades at $431.03 (market cap $46.49B). The key difference: Humana Inc is far larger — about 9.9× Flagstar Bank NA's market cap, and Humana Inc pays the higher dividend (0.91%). Which is the better fit depends on your goals — on Pluang, investors hold Flagstar Bank NA for 22 Days and Humana Inc for 51 Days on average.
| FLG | HUM | |
|---|---|---|
Market Cap | $4.71B | $46.49B |
Volume | 7,410,589 | 2,567,704 |
Sector | Financials | Health |
52-Week High | $15.36 | $409.85 |
52-Week Low | $10.72 | $163.67 |
Typical Hold Time | 22 Days | 51 Days |
Enterprise Value | $15.25B | $53.84B |
Dividend Yield | 0.35% | 0.91% |
Signals from Pluang's Aura AI — not financial advice
Flagstar Bank (FLG) trades at $11.32, showing modest daily gains of 0.18%. The stock faces bearish technical signals with all moving averages indicating selling pressure, though oscillators are neutral. Fundamentally, the company reported a Q2 2026 earnings miss but maintains profitability with a net income margin of 2.3%. Recent developments include a strategic core banking partnership with Fiserv and a $250 million share repurchase program announced in July 2026.
Analyst consensus remains bullish with a $17.07 price target (60% buy ratings), suggesting significant upside potential. However, risks include recent earnings volatility, high P/E ratio of 378, and negative operating cash flow in 2025. The stock trades below book value (P/B 0.62), offering value opportunity if operational improvements continue.
Humana (HUM) trades at $431.03, up 8.71% over the past day, reflecting strong momentum following a Barclays upgrade and positive earnings beats. The stock exhibits a bullish technical trend, with support at $378 and resistance at $394. Revenue has grown steadily from $92.9B in 2022 to $129.7B in 2025, though net income margins have compressed to 0.88%. Analyst consensus is a Buy with a $457.05 price target, and recent news highlights corporate initiatives and institutional investments.
The outlook for HUM is cautiously optimistic, driven by revenue growth and analyst support, but risks include margin pressure and regulatory scrutiny. Investment opportunity lies in execution of Medicare Advantage strategies, while key risks involve competitive pressures and potential fiduciary concerns highlighted in recent shareholder notices.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →